Viewing nowTorvis Tablet (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Person Co., Ltd.

MFDS item code 201401922 · Approved 2014.04.18 · Insurance code 657400970
Improvement of hyperlipidemia and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication is used to reduce the risk of cardiovascular diseases. It particularly lowers the risk of myocardial infarction and stroke in adults with multiple risk factors or in patients with type 2 diabetes, and reduces the risk of complications in patients with chronic stable angina and those who have undergone vascular surgery. It also helps to reduce the risk of non-fatal myocardial infarction, stroke, vascular surgery, hospitalization due to congestive heart failure, and angina in patients with heart disease. In terms of treating hyperlipidemia, it is effective in lowering total cholesterol and LDL cholesterol levels in patients with primary hypercholesterolemia and dyslipidemia, while increasing HDL cholesterol levels. It is also used as an adjunct for certain dyslipidemia patients who do not respond to dietary changes and for patients with homozygous familial hypercholesterolemia. This medication applies to pediatric patients who meet specific criteria for familial hypercholesterolemia. This medication is used for cardiovascular health and the improvement of dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients 70 years of age and older are similar to those in the general adult population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle issues, so if there is severe muscle pain or weakness or a significant increase in muscle enzyme levels, use should be stopped immediately. This medication should not be used in individuals with certain diseases or conditions such as liver disease, pregnant women, children under 10 years old, and people taking specific medications. Those with liver or kidney problems, alcoholics, elderly individuals, and those at high risk for myopathy should use this medication with great caution and regular examinations under a doctor's guidance are necessary. While taking this medication, various side effects may occur, such as liver function abnormalities, allergic reactions, digestive disorders, headaches, and muscle pain. If symptoms are severe or persistent, one should consult a healthcare professional. Particularly, this medication may have a high potential for interactions with other drugs, so if you are currently taking any medications, you must inform your doctor or pharmacist, and it is advisable to avoid certain foods like grapefruit juice. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should ensure proper contraception while on the medication. There is no specific antidote for overdose, so it is important to adhere to the dosage and seek immediate medical attention if unusual symptoms arise. This medication should be kept out of the reach of children and stored safely in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture, so it should be stored in a sealed container. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius at room temperature. This way, the effectiveness and safety of the medication can be preserved for a long time.
White round film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Person Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.